España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Eterna Therapeutics
ERNA
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.5701
-0.06
-10.23%
Pre-Market: 8:05 AM EDT
Get Report
Comment
Eterna Therapeutics (ERNA) Forecast
News
Earnings
Eterna Therapeutics (ERNA) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Eterna Therapeutics (NASDAQ:ERNA) Stock
Eterna Therapeutics Stock (NASDAQ: ERNA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, January 23, 2025
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Thursday, January 16, 2025
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Tuesday, January 14, 2025
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Eterna Therapeutics shares are trading higher...
Benzinga Newsdesk
Eterna Therapeutics Reports Preclinical Study...
Benzinga Newsdesk
Friday, January 03, 2025
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Wednesday, December 04, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Eterna Therapeutics shares are trading higher...
Benzinga Newsdesk
Tuesday, December 03, 2024
Eterna Therapeutics Launches Research To Eval...
Benzinga Newsdesk
Monday, November 25, 2024
Eterna Therapeutics Announces Stock Repurchas...
Benzinga Newsdesk
Tuesday, November 19, 2024
Why Symbotic Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Monday, November 18, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Why Tesla Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Thursday, November 14, 2024
Eterna Therapeutics Regains Nasdaq Compliance
Benzinga Newsdesk
Wednesday, October 30, 2024
Eterna Therapeutics Completes Strategic Finan...
Benzinga Newsdesk
Thursday, October 17, 2024
Eterna Therapeutics And Factor Bioscience Ann...
Benzinga Newsdesk
Wednesday, October 02, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Thursday, September 26, 2024
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Wednesday, September 25, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Monday, June 03, 2024
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Friday, May 10, 2024
Eterna Therapeutics Presents Development Of B...
Benzinga Newsdesk
Tuesday, May 07, 2024
Eterna Therapeutics To Present at The ASGCT 2...
Benzinga Newsdesk
Friday, March 22, 2024
Eterna Therapeutics Inc On March 19, Received...
Benzinga Newsdesk
Friday, February 02, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Thursday, February 01, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Thursday, December 21, 2023
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Wednesday, December 20, 2023
Eterna Therapeutics Appointed Sanjeev Luther ...
Benzinga Newsdesk
Eterna Therapeutics 13G Filing Shows IAF, LLC...
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Friday, December 15, 2023
Eterna Therapeutics Announces $9.2M Convertib...
Benzinga Newsdesk
Tuesday, December 12, 2023
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Thursday, December 07, 2023
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Wednesday, December 06, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Friday, December 01, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Wednesday, September 06, 2023
EXCLUSIVE: Cell Therapy Player Lineage Cell Therapeutics Starts Development Activities Under Licensing Pact With Eterna Therapeutics
Vandana Singh
EXCLUSIVE: Lineage Cell Therapeutics Tells Be...
Benzinga Newsdesk
Thursday, July 13, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Friday, June 02, 2023
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Friday, May 26, 2023
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Friday, May 19, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Wednesday, May 17, 2023
Eterna Therapeutics And Factor Bioscience Announce New Data on Multi-Cell-Type Therapeutic Approach At American Society Of Gene & Cell Therapy 26th Annual Meeting
Happy Mohamed
Thursday, May 04, 2023
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Tuesday, May 02, 2023
Eterna Therapeutics Acquires Allogeneic Immun...
Benzinga Newsdesk
Tuesday, April 11, 2023
Eterna Therapeutics And Lincoln Park Capital Enter Into A 2-Year Common Stock Purchase Agreement For Up To $10M
Happy Mohamed
Monday, March 20, 2023
Eterna Therapeutics Q4 EPS $(1.24) May Not Compare To $(2.40) Estimate
Michael Horton
Wednesday, February 22, 2023
Eterna Therapeutics Enters Into Option And License Agreement With Lineage Cell Therapeutics To Develop Hypoimmune Pluripotent Cell Lines For Multiple Neurology Indications
Happy Mohamed
EXCLUSIVE: Lineage Cell Inks Exclusive Agreement For Novel Cell-Based Therapies With Potential In Neurology
Vandana Singh
Wednesday, January 04, 2023
Eterna Therapeutics Appoints Matt Angel, Ph.D...
Benzinga Newsdesk
Wednesday, December 07, 2022
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
What's Going On With Eterna Therapeutics Stock Today?
Adam Eckert
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
